Leukocyte immunoglobulin-like receptor
From Proteopedia
(Difference between revisions)
| Line 13: | Line 13: | ||
**[[1g0x]], [[1ufu]] – hLIR-1 ligand-binding domain D1D2– human <br /> | **[[1g0x]], [[1ufu]] – hLIR-1 ligand-binding domain D1D2– human <br /> | ||
**[[1ugn]], [[1vdg]] – hLIR-1 ligand-binding domain D1D2 (mutant) <br /> | **[[1ugn]], [[1vdg]] – hLIR-1 ligand-binding domain D1D2 (mutant) <br /> | ||
| - | **[[6ewa]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + peptide<br /> | ||
| - | **[[6ewo]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + desmuslin peptide<br /> | ||
**[[4ll9]] – hLIR-1 ligand-binding domain D3D4 <br /> | **[[4ll9]] – hLIR-1 ligand-binding domain D3D4 <br /> | ||
| + | |||
| + | *LIR-1 complexes | ||
| + | |||
| + | **[[1p7q]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + POL polyprotein peptide<br /> | ||
| + | **[[5knm]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + peptide<br /> | ||
| + | **[[4no0]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + lymphocyte-specific protein peptide<br /> | ||
| + | **[[3d2u]] – hLIR-1 ligand-binding domain D1D2 + herpesvirus UL18 + β-2 microglobulin + actin peptide<br /> | ||
| + | **[[6ewa]], [[6ewc]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + peptide<br /> | ||
| + | **[[6ewo]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + desmuslin peptide<br /> | ||
| + | **[[6aee]], [[6k60]] – hLIR-1 ligand-binding domain D1D2D3D4 + class I MHC + β-2 microglobulin + histone peptide<br /> | ||
*LIR-2 | *LIR-2 | ||
| Line 21: | Line 29: | ||
**[[4lla]] – hLIR-2 ligand-binding domain D3D4 <br /> | **[[4lla]] – hLIR-2 ligand-binding domain D3D4 <br /> | ||
**[[2otp]] – hLIR-2 ligand-binding domain D1D2 <br /> | **[[2otp]] – hLIR-2 ligand-binding domain D1D2 <br /> | ||
| + | **[[6bcs]] – hLIR-2 ligand-binding domain D1D2 + benzamidine<br /> | ||
| + | **[[6aed]] – hLIR-2 ligand-binding domain D1D2D3D4 (mutant)<br /> | ||
**[[2dyp]] – hLIR-2 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + H2A peptide<br /> | **[[2dyp]] – hLIR-2 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + H2A peptide<br /> | ||
| Line 26: | Line 36: | ||
**[[3q2c]] – hLIR-4 N-terminal domain <br /> | **[[3q2c]] – hLIR-4 N-terminal domain <br /> | ||
| + | **[[6k7o]] – hLIR-4 N-terminal domain + antibody <br /> | ||
*LIR-5 | *LIR-5 | ||
| Line 31: | Line 42: | ||
**[[3p2t]] – hLIR-5 ligand-binding domain D1D2 <br /> | **[[3p2t]] – hLIR-5 ligand-binding domain D1D2 <br /> | ||
| - | *LIR-1 complexes | ||
| - | |||
| - | **[[1p7q]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + POL polyprotein peptide<br /> | ||
| - | **[[5knm]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + peptide<br /> | ||
| - | **[[4no0]] – hLIR-1 ligand-binding domain D1D2 + class I MHC + β-2 microglobulin + lymphocyte-specific protein peptide<br /> | ||
| - | **[[3d2u]] – hLIR-1 ligand-binding domain D1D2 + herpesvirus UL18 + β-2 microglobulin + actin peptide<br /> | ||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 09:48, 31 August 2020
| |||||||||||
3D structures of leukocyte immunoglobulin-like receptor
Updated on 31-August-2020
References
- ↑ Thomas R, Matthias T, Witte T. Leukocyte immunoglobulin-like receptors as new players in autoimmunity. Clin Rev Allergy Immunol. 2010 Apr;38(2-3):159-62. doi:, 10.1007/s12016-009-8148-8. PMID:19548123 doi:http://dx.doi.org/10.1007/s12016-009-8148-8

